Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Whole-Blood Levels of MicroRNA-9 Are Decreased in Patients With Late-Onset Alzheimer Disease

1 Jan 2020

Abstract excerpt

Recent evidence suggests changes in circulating microRNA levels may be promising biomarkers for the clinical diagnosis of Alzheimer disease (AD). We hypothesized that whole-blood microRNAs may be useful to identify individuals with established AD. For this purpose, a sample of community-dwelling women (≥55 years old) carrying the ApoE ∊4 allele were clinically evaluated using the American Psychiatric Association/...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to MicroRNA in disease regulation
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32301334
DOI: 10.1177/1533317520911573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Whole-Blood Levels of MicroRNA-9 Are Decreased in Patients With Late-Onset Alzheimer DiseasePMID 32301334Read ↗

Plasma microRNAs as potential biomarkers in early Alzheimer disease expressionSemantic proximity Read ↗

MicroRNAs as Candidate Biomarkers for Alzheimer’s DiseaseSemantic proximity Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

Alzheimer's disease: presence and role of microRNAs.Semantic proximity Read ↗

MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapySemantic proximity Read ↗

Machine learning to detect Alzheimer’s disease from circulating non-coding RNAsSemantic proximity Read ↗

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic BiomarkersSemantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspectiveSemantic proximity Read ↗

MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targetsSemantic proximity Read ↗

MicroRNAs in Alzheimer’s DiseaseSemantic proximity Read ↗

Rethinking Alzheimer’s: Novel miRNAs Illuminate a Disease Beyond the BrainSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.